Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Lysosomal acid lipase reported to reduce atherosclerotic plaque formation

Jan. 22, 2004

Novel NHE-1 inhibitors in early development at Aventis

Jan. 21, 2004

Esperion Therapeutics plans to develop therapies based on PPARdelta agonists

Jan. 20, 2004

Stevioside found safe and effective in mild essential hypertension

Jan. 16, 2004

Ambrisentan enters phase III clinical development

Jan. 13, 2004

Cardiac chymase: a novel target in post-MI treatment

Jan. 13, 2004

Novartis identifies aliskiren-related renin inhibitors as antihypertensive agents

Jan. 12, 2004

Single and dual GSK-3/PKC inhibitors prepared and tested at Janssen

Jan. 12, 2004

PCALC-36, a new Na+/K+-ATPase inhibitor with a unique mechanism of action

Jan. 9, 2004

A new phase II clinical trial to evaluate two furosemide formulations in CHF patients

Jan. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...